Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Clin Neuropsychol ; 37(3): 491-505, 2023 04.
Article in English | MEDLINE | ID: mdl-35614554

ABSTRACT

Objective: Given the decreased clinical training opportunities during the COVID-19 pandemic, this study aimed to provide insights into how training directors and supervising neuropsychologists from internships offering neuropsychology training adjusted expectations of competitive applicants. Method: Respondents (n = 50) from internships offering at least an "exposure" in neuropsychology completed questions about how training expectations of competitive applicants have changed because of the COVID-19 pandemic. Results: Most respondents reported decreased expectations for clinical hours and research productivity and increased expectations for telehealth experience and involvement in working with culturally diverse populations. Additionally, more than half of respondents from programs at university-affiliated and Veteran Affairs medical centers indicated reduced expectations for average number of integrated reports. Furthermore, compared to respondents at Veteran Affairs medical centers, respondents at university-affiliated medical centers stated decreased expectations for average number of paper presentations. Conclusions: The COVID-19 pandemic has motivated subtle changes in expectations of competitive neuropsychology-oriented internship applicants, specific to clinical experience, research productivity, and prioritization of certain application materials. Qualitative responses suggest that many respondents endeavored to improve applicant screening rather than lower expectations for applicants. As a result, consistent with previous recommendations, the importance of fit between trainee and training program should continue to be emphasized by prospective applicants. These findings have important implications for trainees for the next several years, as graduate students at all stages of training ultimately progress to the internship application stage.


Subject(s)
COVID-19 , Internship and Residency , Humans , Neuropsychology , Pandemics , Motivation , Neuropsychological Tests , Surveys and Questionnaires
2.
Neurocase ; 29(2): 29-36, 2023 04.
Article in English | MEDLINE | ID: mdl-38678304

ABSTRACT

Most individuals recover quickly from a concussion; however, youth who sustain multiple concussions may be at risk for long-term cognitive impairments. This case study examines the neuropsychological performance of a 13-year-old malewith five head injuries. After his first concussion during study participation (fourth injury overall), several improvements were observed, likely due to practice effects, yet after sustaining another concussion <2 years later,declines were observed in visuoconstruction, verbal memory, and intellectual functioning. Across serial re-evaluation, his vocabulary knowledge declined, and fewer improvements were observed than anticipated when accounting for serial practice effects, highlighting the possible cumulative impact of multiple concussions.


Subject(s)
Athletic Injuries , Brain Concussion , Neuropsychological Tests , Humans , Brain Concussion/psychology , Brain Concussion/complications , Adolescent , Male , Athletic Injuries/complications , Cognitive Dysfunction/etiology , Cognitive Dysfunction/physiopathology
3.
Arch Clin Neuropsychol ; 37(3): 704-721, 2022 Feb 22.
Article in English | MEDLINE | ID: mdl-34849534

ABSTRACT

OBJECTIVE: The specialty of clinical neuropsychology has experienced significant professional growth and increasing standardization of educational and training guidelines over the past 20 years. Previous literature demonstrated the importance of routine distribution of selection criteria used by training directors and supervising neuropsychologists for competitive applicants aiming to specialize in neuropsychology during internship. This study examined supervisors' updated expectations for competitive applicants from a more diverse sample of doctoral internship programs offering neuropsychological training. These data also provide cross-sectional and longitudinal comparisons to help trainees tailor their graduate training experiences. METHOD: The sample included training directors and/or supervising neuropsychologists from 80 internship programs (73.4% of submitted surveys). Spearman correlations, analyses of variance, and chi-square tests of independence were conducted for cross-sectional and longitudinal comparisons. RESULTS: Clinical experience in assessment and the personal interview were consistently the two most prioritized criteria across all groups, whereas prioritization of the additional criteria was variable based on the program's characteristics. Internship programs generally preferred practica experience at university-affiliated medical centers, Veterans Affairs medical centers, and private/community-based hospitals. University-affiliated medical centers and internships offering ≥50% neuropsychology training showed similar preferences for applicants with a depth and breadth of graduate school experience in neuropsychology. Longitudinally, the applicant expectations for programs offering ≥50% neuropsychology training remained largely unchanged between 2000 and 2020. CONCLUSIONS: This study updated expectations for competitive applicants from a diverse sample of neuropsychology training programs, underscored the importance of fit between trainee and program, and demonstrated consistency over time for trainees seeking neuropsychology training during internship.


Subject(s)
Internship and Residency , Neuropsychology , Cross-Sectional Studies , Humans , Motivation , Neuropsychological Tests , Neuropsychology/education , Surveys and Questionnaires
5.
J Psychoactive Drugs ; 54(3): 224-232, 2022.
Article in English | MEDLINE | ID: mdl-34461814

ABSTRACT

With the recent rise in cannabis use and reported association between use and biopsychosocial risk, identifying factors to reduce use is important. This study examined the association between religion and spirituality factors and cannabis initiation and use. An online survey sample (N = 935) provided demographic, childhood religious affiliation (association with a specific religious group), religiosity (e.g., church attendance, prayer), spirituality, and substance use-related information. As hypothesized, participants with higher religiosity scores were less likely to be regular cannabis users (p = .017). However, cannabis use (early initiation, regular use, recent use, problematic use) was not associated with religious affiliation or with religious affiliation type (religions grouped by identifiable characteristics). Nevertheless, religious affiliation type was associated with recent alcohol use (p < .001) and recent intoxication (p = .006) among participants who reported cannabis use at least once, supporting previous research suggesting an inverse relation between religiosity and substance use. Overall, childhood religious affiliation type was not associated with cannabis use milestones as had been previously reported for alcohol use milestones. This suggests important differences between alcohol and cannabis use characteristics (e.g., social acceptability, recreational vs. medicinal substance) that may have implications for future substance use research, prevention, and treatment.


Subject(s)
Cannabis , Religion , Substance-Related Disorders , Adult , Alcohol Drinking/psychology , Child , Humans , Spirituality , Substance-Related Disorders/psychology
6.
J Int Neuropsychol Soc ; 27(6): 581-591, 2021 07.
Article in English | MEDLINE | ID: mdl-34261552

ABSTRACT

OBJECTIVE: The variability of findings in studies examining the effects of chronic cannabis use on neuropsychological functioning highlights the importance of examining contributing factors. Few studies examine the role of sex in the relationship between cannabis and neuropsychological functioning, despite known neurobiological structural differences between males and females. This study examined whether males and females experience differential cognitive effects of chronic cannabis use. METHOD: Chronic cannabis users (3+ days per week for >12 months, n = 110, 72% male) and non-users (n = 71, 39% male) completed a neuropsychological test battery. Two multivariate analyses of covariance (MANCOVAs) examined for sex differences in performance within users and non-users on neuropsychological tests, controlling for potential confounding variables. Bonferroni corrections were applied to adjust for multiple comparisons. RESULTS: Male and female cannabis users did not differ in cannabis use variables. Female cannabis users performed better than males on multiple subtests of the California Verbal Learning Test-II (CVLT-II), a verbal learning and memory test. Male cannabis users performed better than female users on Trial 1 of the CVLT-II (p = .002), and Trail Making Test B (p = .001), which measure attention and cognitive flexibility, respectively. Non-user males and females performed comparably, with the exception of Trail Making Test B (p = .001). CONCLUSIONS: Results suggest that chronic cannabis use differentially impacts males and females, with females exhibiting better verbal learning and memory despite males demonstrating better attention and cognitive flexibility. Further research is needed to understand the potential protective mechanism of female sex on learning and memory effects of cannabis use.


Subject(s)
Cannabis , Attention , Humans , Neuropsychological Tests , Protective Factors , Verbal Learning
7.
J Psychiatr Res ; 139: 185-192, 2021 07.
Article in English | MEDLINE | ID: mdl-34087515

ABSTRACT

OBJECTIVE: To compare the prevalence of cognitive symptoms and their functional impact by age group accounting for depression and number of other health conditions. METHODS: We analyzed data from the 2011 Behavioral Risk Factor Surveillance System, a population-based, cross-sectional telephone survey of US adults. Twenty-one US states asked participants (n = 131, 273) about cognitive symptoms (worsening confusion or memory loss in the past year) and their functional impact (interference with activities and need for assistance). We analyzed the association between age, depression history and cognitive symptoms and their functional impact using logistic regression and adjusted for demographic characteristics and other health condition count. RESULTS: There was a significant interaction between age and depression (p < 0.0001). In adults reporting depression, the adjusted odds of cognitive symptoms in younger age groups (<75 years) were comparable or greater to those in the oldest age group (≥75 years) with a peak in the middle age (45-54 years) group (OR 1.9 (95% Confidence Interval: 1.4-2.5). In adults without depression, adults <75 years had a significantly lower adjusted odds of cognitive symptoms compared to the oldest age group with the exception of the middle-aged group where the difference was not statistically significant. Over half of adults under age 65 with depression reported that cognitive symptoms interfered with life activities compared to 35.7% of adults ≥65 years. CONCLUSIONS: Cognitive symptoms are not universally higher in older adults; middle-aged adults are also particularly vulnerable. Given the adverse functional impact associated with cognitive symptoms in younger adults, clinicians should assess cognitive symptoms and their functional impact in adults of all ages and consider treatments that impact both cognition and functional domains.


Subject(s)
Cognition , Depression , Aged , Behavioral Risk Factor Surveillance System , Cross-Sectional Studies , Depression/epidemiology , Humans , Middle Aged , Prevalence
9.
Article in English | MEDLINE | ID: mdl-33822857

ABSTRACT

OBJECTIVE: Administering the noose item of the Boston Naming Test (BNT) has been questioned given the cultural, historical, and emotional salience of the noose in American culture. In response, some have modified the BNT by skipping/removing this item and giving the point as if the examinee responded correctly. It is unknown, however, whether modifying standardized administration and scoring in this manner affects clinical interpretation. In the present study, we examined the prevalence of noose item failure, whether demographic and clinical characteristics differed between those who responded correctly versus failed the item, and whether giving a point to those who failed affected clinical interpretation. METHOD: Participants included a mixed clinical sample of 762 adults, ages 18-88 years, seen for neuropsychological evaluation at one of five sites within the USA. RESULTS: Those who failed the item (13.78%) were more likely to be female, non-White, and have primary diagnoses of major neurocognitive disorder, epilepsy, or neurodevelopmental disorder. Noose item failure was associated with lower BNT total score, fewer years of education and lower intellectual functioning, expressive vocabulary, and single word reading. Giving a point to those who failed the item resulted in descriptor category change for 17.1%, primarily for patients with poor overall BNT performance. CONCLUSIONS: Only a small percentage of patients fail the noose item, but adding a point for these has an impact on score interpretation. Factors associated with poorer overall performance on the BNT, rather than specific difficulty with the noose item, likely account for the findings.

10.
Appl Neuropsychol Adult ; 28(4): 486-496, 2021.
Article in English | MEDLINE | ID: mdl-31519112

ABSTRACT

Given the prevalence of compensation seeking patients who exaggerate or fabricate their symptoms, the assessment of performance and symptom validity throughout testing is vital in neuropsychological evaluations. Two of the most commonly utilized performance validity tests (PVTs) are the Word Memory Test (WMT) and the Test of Memory Malingering (TOMM). While both have proven successful in detecting invalid performance, some studies suggest greater sensitivity in the WMT relative to the TOMM. To improve upon previous research, this study compared performance in individuals who completed both the WMT and TOMM during a neuropsychological evaluation. Participants included 268 cases from a clinical private practice consisting of primarily disability claimants. One-way multivariate analysis of variance (MANOVA) compared neuropsychological performance of participants who passed both PVTs (n = 198) versus those who failed the WMT but passed the TOMM (n = 70). Global suppression of neuropsychological scores was found for participants who failed the WMT but passed the TOMM, as well as more psychiatric symptoms reported on questionnaires, relative to those who passed both PVTs. These findings suggest that those passing the TOMM but failing the WMT demonstrated performance invalidity, which illustrates the WMT's enhanced sensitivity.


Subject(s)
Malingering , Memory Disorders , Humans , Malingering/diagnosis , Memory Disorders/diagnosis , Memory Disorders/etiology , Memory and Learning Tests , Neuropsychological Tests , Reproducibility of Results
11.
Int J Geriatr Psychiatry ; 35(9): 982-988, 2020 09.
Article in English | MEDLINE | ID: mdl-32400901

ABSTRACT

OBJECTIVES: The short form or s-allele variant of the serotonin transporter polymorphism (5-HTTLPR), as compared with the long-form or l-allele variant, has been associated with the presence of cognitive dysfunction, and particularly memory impairment in older adults. This body of cross-sectional work has culminated in the hypothesis that presence of the s-allele predicts greater memory decline in older adults. Yet, to date, there are no longitudinal studies that have investigated this issue. METHODS/DESIGN: Here, we examine 109 community-dwelling older adults (mean and SD of age = 70.7 ± 8.7 years) who underwent blood draw for genotyping, cognitive, and psychological testing at baseline, 12-, and 24-monthfollow-ups. RESULTS: Multilevel modeling found that s-allele carriers (ss or ls) performed worse than ll homozygotes at baseline on delayed verbal recall. Yet, s-allele carriers' memory performance was stable over the two-yearfollow-up period, while l-allele homozygotes experienced significant memory decline. l-allele homozygote status was associated with both increased cortisol and decreased memory over time, resulting in attenuated verbal memory performance differences compared to s-allele carriers with age. CONCLUSIONS: Overall, our findings do not support the hypothesis that presence of the 5-HTTLPRs-allele is a marker for memory decline in older adults. J Am Geriatr Soc 68:-, 2020.


Subject(s)
Hydrocortisone , Serotonin Plasma Membrane Transport Proteins , Aged , Alleles , Cross-Sectional Studies , Genotype , Humans , Serotonin Plasma Membrane Transport Proteins/genetics
12.
Arch Clin Neuropsychol ; 35(5): 469-481, 2020 Jul 24.
Article in English | MEDLINE | ID: mdl-32186667

ABSTRACT

OBJECTIVE: Although research shows that abnormal scores are common in adults, fewer studies examine the frequency of abnormal scores within children. The present study assessed how specific tests, cognitive domains, and patient factors affect the likelihood of abnormally low scores among healthy youth athletes. METHODS: Youth athletes (n = 85, Mage = 11.72, SD = 2.23) completed a comprehensive neuropsychological battery (N = 23 tests) during baseline testing for a sport-related concussion clinical research program. "Abnormal" scores were defined using cutoffs at 1, 1.5, and 2 standard deviations (SDs) below the population mean. Univariate and multivariate Poisson regression models examined abnormal test scores as a function of age, sex, ethnicity, and Full-Scale Intelligence Quotient (FSIQ). RESULTS: Using cutoffs of 1, 1.5, and 2 SDs, the percent of healthy participants with at least one abnormal test score was 61.2, 36.5, and 22.4%, respectively, indicating a high proportion of healthy participants with abnormal scores and low specificity for tests using these cutoffs. In univariate Poisson regression analyses, FSIQ and abnormal score were negatively correlated (p < .001), wherein lower FSIQ was associated with more abnormal scores. In multivariate regression analyses, lower performance on executive function, memory, and processing speed tests was significantly associated with an increased frequency of abnormal scores. CONCLUSIONS: Abnormally low scores in healthy youth occur frequently and do not necessarily represent functional deficits. Cutoffs of 2 SDs should be considered for many tests to increase specificity and reduce the risk of false positive errors that could lead to negative clinical outcomes.


Subject(s)
Athletes , Athletic Injuries , Brain Concussion , Sports , Adolescent , Adult , Athletes/psychology , Athletic Injuries/complications , Athletic Injuries/diagnosis , Brain Concussion/diagnosis , Child , Humans , Memory , Neuropsychological Tests
13.
Appl Neuropsychol Child ; 9(4): 329-336, 2020.
Article in English | MEDLINE | ID: mdl-31918597

ABSTRACT

In pediatric evaluations, performance validity test (PVT) selection is often constrained by reading level, developmental appropriateness of stimuli, and administration time. The Rey 15 Item Test (FIT) addresses these constraints, and ranks among the most frequently used PVTs. Unfortunately, research indicates poor sensitivity of the FIT recall trial. Boone et al. developed a FIT recognition trial and demonstrated in an adult sample that its use increased sensitivity while maintaining high specificity. These results are promising, but, to the authors' knowledge, have only been replicated once in a pediatric sample. The present study examined the FIT plus recognition trial in a sample of 72 young athletes ages 8-16 years. All data for the present study were collected during baseline cognitive evaluations. The Test of Memory Malingering (TOMM) was used as the comparison criterion. Receiver operating characteristic curve analyses showed the addition of the recognition trial did not substantially improve sensitivity of the FIT. There was a surprising lack of concordance between TOMM and FIT scores, and, whereas the FIT correlated with multiple cognitive measures, the TOMM did not correlate with any other measures. Results suggest the FIT is not appropriate for pediatric clinical care, even with the additional recognition trial.


Subject(s)
Independent Living/psychology , Malingering/diagnosis , Malingering/psychology , Memory and Learning Tests/standards , Recognition, Psychology/physiology , Adolescent , Athletic Injuries/diagnosis , Athletic Injuries/psychology , Brain Concussion/diagnosis , Brain Concussion/psychology , Child , Female , Humans , Male , Neuropsychological Tests/standards , Reproducibility of Results
14.
J Alzheimers Dis ; 73(1): 77-86, 2020.
Article in English | MEDLINE | ID: mdl-31743997

ABSTRACT

BACKGROUND: Existing literature on factors associated with supportive care service (SCS) use is limited. A better understanding of these factors could help tailor SCS to the needs of frequent users, as well as facilitate targeted outreach to populations that underutilize available services. OBJECTIVE: To investigate the prevalence of SCS use and to identify factors associated with, and barriers to, service use. METHODS: California Alzheimer's Disease Center patients with AD (n = 220) participated in the study from 2006-2009. Patients and their caregivers completed assessments to determine SCS use. Cognitive, functional, and behavioral status of the patients were also assessed. A two-part hurdle analysis identified 1) factors associated with any service use and 2) service use frequency among users. RESULTS: Forty percent of participants reported using at least one SCS. Patients with more impaired cognition and activities of daily living and more of the following: total number of medications, comorbid medical conditions, and years of education were more likely to use any SCS (p < 0.05). Factors associated with more frequent SCS use included younger age, more years of education, older age of AD onset, female gender, and having a spouse or relative for a caregiver (p < 0.05). Caregivers frequently indicated insufficient time as a reason for not receiving enough services. CONCLUSION: Factors associated with any SCS use mostly differed from those associated with SCS frequency, suggesting different characteristics between those who initiate versus those who continue SCS use. Our findings highlight the importance of targeted education on services and identifying barriers to long-term SCS use.


Subject(s)
Alzheimer Disease/therapy , Caregivers/psychology , Activities of Daily Living , Age Factors , Age of Onset , Aged , Aged, 80 and over , Alzheimer Disease/psychology , California , Comorbidity , Educational Status , Female , Health Services , Humans , Male , Mental Status and Dementia Tests , Quality of Life , Social Support , Socioeconomic Factors
15.
Appl Neuropsychol Child ; 8(3): 206-212, 2019.
Article in English | MEDLINE | ID: mdl-29412011

ABSTRACT

Performance validity testing in children undergoing neuropsychological testing is a growing research area. Accurate identification of performance validity is necessary to avoid invalid assessment conclusions. In the present research, a forced choice (FC) trial was created for the California Verbal Learning Test - Children's Edition (CVLT-C), modeled after the established California Verbal Learning Test - Second Edition (CVLT-II) FC trial. Distractor words were taken directly from the CVLT-II FC Standard Form, with about half being concrete (n = 8) and half abstract (n = 7). The order of the items was organized similarly to the CVLT-II FC to ensure that items from within the same category were not sequential. The Test of Memory Malingering was administered for comparison, and three embedded measures that have previously been validated in adults were also calculated. The CVLT-C FC trial was administered to 40 children, aged 6-16 (M = 12.08, SD = 3.13). Average full scale IQ was 97.3 (SD = 12.41, range = 71-123). Ninety-three percent of examinees performed perfectly on the CVLT-C FC, suggesting high specificity, which is similar to findings for the CVLT-II FC normative group (90%). Results from other embedded measures are also presented.


Subject(s)
Malingering/psychology , Memory and Learning Tests , Verbal Learning/physiology , Adolescent , Child , Choice Behavior/physiology , Female , Humans , Male , Memory/physiology , Psychometrics/statistics & numerical data
16.
J Clin Exp Neuropsychol ; 41(2): 133-146, 2019 03.
Article in English | MEDLINE | ID: mdl-30124369

ABSTRACT

Introduction: Research evaluating the neuropsychological effects of cannabis has yielded mixed findings, with some studies finding cognitive deficits in cannabis users (primarily in learning and memory) and others finding no significant effects. It is important to understand how clinicians perceive this discrepancy in the empirical literature. However, no studies have assessed neuropsychologists' beliefs regarding the effects of cannabis on cognitive functioning. Thus, this study sought to evaluate how patient and cannabis-use factors influence neuropsychologists' perceptions of cannabis's cognitive effects. Method: Neuropsychologists (N = 261) read eight vignettes, each depicting cannabis users varying in age, gender, and cannabis-use history (frequency, duration, and recreational/medicinal use). Respondents rated the anticipated effects of cannabis in each vignette on nine cognitive domains. Mixed effects linear regression modeled the ratings of cognitive abilities as a function of neuropsychologist, neuropsychologists' training, vignette, patient age, gender, and frequency/duration/type of cannabis use, and treated neuropsychologist and vignette as random effects. Results: Duration of use had the most notable effect on neuropsychologists' ratings, with a small (0.1 to 0.2 SDs) yet statistically significant (p < .001) negative effect on each cognitive domain. Male gender and medicinal use also predicted lower cognitive ratings. Differences in ratings between neuropsychologists accounted for 73% of the total variability in each domain, whereas variability due to vignette alone was negligible (<1%). Conclusions: Results suggest that neuropsychologists believe that cannabis use results in broad but mild cognitive deficits, consistent with meta-analytic findings of active chronic cannabis users, particularly for males and for individuals using cannabis for medicinal purposes. Interestingly, neuropsychologists expected fewer cognitive effects in recreational cannabis users. Further, duration of use (rather than frequency) was believed to be the primary factor contributing to cognitive deficits.


Subject(s)
Attitude of Health Personnel , Cognition Disorders/chemically induced , Culture , Marijuana Abuse/diagnosis , Neuropsychology , Adult , Age Factors , Cognition Disorders/diagnosis , Cognition Disorders/psychology , Female , Humans , Male , Marijuana Abuse/psychology , Marijuana Smoking/adverse effects , Marijuana Smoking/psychology , Medical Marijuana/adverse effects , Neuropsychological Tests , Risk Factors , Sex Factors , Surveys and Questionnaires
17.
J Pediatr Health Care ; 33(1): 14-25, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30146363

ABSTRACT

INTRODUCTION: Sports-related concussion is a significant pediatric health risk, given the number of children involved in sports and the vulnerability of developing brains. Although most research has focused on high school/college athletes, these findings may not be applicable to younger athletes. METHOD: A mixed-methods analysis examined concussion incidence and sequelae in a cohort of 8- to 13-year-old males (N = 31) playing youth football and their parents. Parents provided background information and completed mood/behavioral questionnaires, and each athlete completed a neuropsychological battery. RESULTS: Eight athletes (26%) had a history of concussion before assessment. Concussion risk was related to lack of medical evaluation in prior concussions, tackling exposure (in both offensive and defensive positions), and multisport participation. There were no cognitive or psychological differences based on concussion history. DISCUSSION: Findings identify factors that may contribute to concussion risk in children and show the need for further research in this understudied population.


Subject(s)
Athletic Injuries/physiopathology , Brain Concussion/physiopathology , Football/injuries , Neurodevelopmental Disorders/epidemiology , Age Factors , Athletic Injuries/complications , Athletic Injuries/epidemiology , Brain Concussion/complications , Brain Concussion/epidemiology , California/epidemiology , Child , Evaluation Studies as Topic , Humans , Male , Neurodevelopmental Disorders/etiology , Neurodevelopmental Disorders/physiopathology , Neuropsychological Tests , Parents , Qualitative Research , Risk Factors , Surveys and Questionnaires
18.
Subst Use Misuse ; 53(14): 2359-2367, 2018 12 06.
Article in English | MEDLINE | ID: mdl-29958041

ABSTRACT

OBJECTIVE: With increasing legalization of medicinal and recreational cannabis, use is on the rise. Research suggests individuals may be able to guess cannabis user status based upon appearance; however, these findings utilized a small sample of photographs that was not balanced on user status or gender. Further, no studies examined whether raters with cannabis experience are better at judging others' cannabis use, or what physical features they use to make these judgments. This study explored these factors using a larger, balanced photograph database. METHOD: An American sample (n = 249, 48.6% female, mean age = 35.19 years) rated 36 photographs (18 cannabis users, 18 nonusers) balanced on gender and age on the likelihood that the photographed individuals use cannabis, producing 8964 ratings. Respondents also reported physical features considered in their ratings, as well as their own cannabis use history. RESULTS: As hypothesized, photographs of users received higher ratings on the Marijuana Use Likelihood Index relative to nonusers. Further, results revealed a gender by rater user status interaction, indicating that raters with no previous cannabis experience rated males higher than females, while raters with cannabis experience did not demonstrate this rating discrepancy. Cannabis use explained over 9% of the variance in ratings across all photographs. CONCLUSIONS: Results suggest individuals do rate cannabis users as more likely to be users, relative to nonusers, based upon appearance alone. These findings have important implications, not only for research on chronic cannabis use effects, but also for social and achievement factors such as potential stigma.


Subject(s)
Drug Users , Judgment , Marijuana Use , Adult , Aged , Female , Humans , Male , Middle Aged , Social Perception , Young Adult
19.
Psychol Assess ; 30(8): 1082-1095, 2018 08.
Article in English | MEDLINE | ID: mdl-29952596

ABSTRACT

This study was designed to examine the potential of the Delis-Kaplan Executive System (D-KEFS) version of the Trail Making Test (TMT) as a performance validity test (PVT). Data were collected from a mixed clinical sample of 157 consecutively referred outpatients (49% male, MAge = 47.1, MEducation = 13.6) undergoing neuropsychological assessment at an academic medical center in the northeastern United States. Sensitivity and specificity of the D-KEFS Trails to psychometrically defined invalid responding was calculated across various cutoffs and criterion PVTs. The D-KEFS Trails produced classification accuracy comparable to the original version of the TMT, hovering around the "Larrabee limit" (.50 sensitivity at .90 specificity). Different cutoffs (age-corrected scaled score ≤5 on Trails 1-3, ≤4 on Trails 4 and ≤8 on Trails 5) were needed to achieve the same classification accuracy across the five trials. Combining multiple cutoffs improved the signal detection performance. The study provides preliminary evidence of the utility of D-KEFS Trails as a PVT. Embedded PVTs are valuable, because they make a multivariate approach to validity assessment feasible. Combining validity indicators is superior to relying on single cutoffs. (PsycINFO Database Record


Subject(s)
Brain Injuries, Traumatic/psychology , Epilepsy/psychology , Mental Disorders/psychology , Trail Making Test , Adult , Cognitive Dysfunction/psychology , Female , Humans , Male , Middle Aged , Multiple Sclerosis/psychology , Neuropsychological Tests , New England , Parkinson Disease/psychology , Psychometrics , Reproducibility of Results
20.
Am J Geriatr Psychiatry ; 26(7): 806-811, 2018 07.
Article in English | MEDLINE | ID: mdl-29709510

ABSTRACT

OBJECTIVE: To examine the relationship between subclinical anxiety and depressive symptoms and objective sleep architecture measures and subjective sleep reports in older adults. METHODS: Community-dwelling older adults (N = 167) self-rated their current severity of anxiety symptoms, depressive symptoms, daytime sleepiness, and global sleep quality. Participants received overnight ambulatory polysomnography to assess sleep architecture. Multivariate linear regression models examined associations between anxiety and depressive symptoms and objective and subjective sleep measures. RESULTS: Significant findings emerged for subjective sleep, with higher depression and anxiety scores associated with worse global sleep quality and greater anxiety scores associated with greater daytime sleepiness. No significant associations were observed between subclinical levels of anxiety or depressive symptoms with sleep architecture. CONCLUSION: Subclinical levels of late-life anxiety and depression have distinct associations with subjective sleep disturbance. Findings implicate subjective measures of sleep quality and daytime sleepiness as stronger trait markers for subthreshold psychiatric symptoms than objective sleep biomarkers.


Subject(s)
Anxiety/epidemiology , Depression/epidemiology , Prodromal Symptoms , Sleep Wake Disorders/epidemiology , Aged , Aged, 80 and over , California/epidemiology , Comorbidity , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Monitoring, Ambulatory , Polysomnography , Self Report
SELECTION OF CITATIONS
SEARCH DETAIL
...